1-3 of 3
Pierre Vera, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Profile and FDG-PET/CT Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B Cell Lymphoma

Anne-Ségolène Cottereau, MD, Hélène Lanic, MD, Michel Meignan, MD PhD, Pierre Vera, MD PhD, Hervé Tilly, MD PhD, Fabrice Jardin, MD PhD, Stéphanie Becker, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1452.
https://doi.org/10.1182/blood.V126.23.1452.1452
Published: 2015
Journal Articles

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography SUVmax Reduction Is Superior to Visual Analysis to Predict Early patient's Outcome In Diffuse Large B-Cell Lymphoma

Rene-Olivier Casasnovas, MD, Michel Meignan, MD, Alina Berriolo-Riedinger, MD, Stephane Bardet, MD, Anne Julian, MD, Catherine Thieblemont, MD, Pierre Vera, MD, Serge Bologna, MD, Josette Briere, MD, Jean-Philippe Jais, MD, Corinne Haoiun, MD, Bertrand Coiffier, MD, PhD, Franck Morschhauser, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 320.
https://doi.org/10.1182/blood.V116.21.320.320
Published: 2010
Journal Articles

Patient-Specific Three Dimensional (3D) Dosimetry for 90 Y Ibritumomab Tiutexan (Zevalin®) in Patients with Follicular Lymphoma.

Karine Assié, PhD, Arnaud Dieudonné, PhD, Isabelle Gardin, PhD, Irène Buvat, PhD, Hervé Tilly, MD, Pierre Vera, MD
Journal: Blood
Blood (2005) 106 (11): 4780.
https://doi.org/10.1182/blood.V106.11.4780.4780
Published: 2005